Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children
Kobbe R, Rau C, Schulze-Sturm U, Stahl F, Fonseca-Brito L, Diemert A, Lütgehetmann M, Addo M, Arck P, Weskamm L
PEDIATR INFECT DIS J. 2024;43(12):1200-1203.

Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany
Mauritz M, von Both U, Dohna-Schwake C, Gille C, Hasan C, Huebner J, Hufnagel M, Knuf M, Liese J, Renk H, Rudolph H, Schulze-Sturm U, Simon A, Stehling F, Tenenbaum T, Zernikow B
EUR J PEDIATR. 2024;183(3):987-999.

Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus
Villaverde S, Pedrero-Tomé R, Papaevangelou V, Syridou G, Karagiannidou S, Lyall H, Payne H, Frick M, Soler-Palacín P, Baquero-Artigao F, Rodríguez-Molino P, Fortuny-Guasch C, Rios-Barnés M, Sánchez-Mateos M, Saavedra-Lozano J, Bringué X, Moliner E, Castells L, Muga O, Vives-Oños I, Gkentzi D, Lombardi G, Tagarro A, Colino E, Couceiro J, Rojo P, de Vergas J, Blázquez-Gamero D
PEDIATR INFECT DIS J. 2024 [Epub ahead of print].

HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
Baumann U, Schulze-Sturm U, Königs C
GYNAKOLOGIE. 2023;56:47-57.

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Drysdale S, Cathie K, Flamein F, Knuf M, Collins A, Hill H, Kaiser F, Cohen R, Pinquier D, Felter C, Vassilouthis N, Jin J, Bangert M, Mari K, Nteene R, Wague S, Roberts M, Tissières P, Royal S, Faust S
NEW ENGL J MED. 2023;389(26):2425-2435.

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
Ettemeyer M, Florey M, Tanida K, Jochum J, Schulze-Sturm U, Lütgehetmann M, Baehr M, Addo M, Schmiedel S, Rohde H, Koch T
INFECTION. 2023;51(5):1569-1575.

Penicillinallergie: Sicher und effektiv ausschließen
Koch T, Leubner H, Brehm T, Witte J
Deutsches Ärzteblatt. 2023;120(18):822-824.

Reduced Humoral and Cellular Immune Response to Primary COVID-19 mRNA Vaccination in Kidney Transplanted Children Aged 5–11 Years
Lalia J, Schild R, Lütgehetmann M, Dunay G, Kallinich T, Kobbe R, Massoud M, Oh J, Pietzsch L, Schulze-Sturm U, Schuetz C, Sibbertsen F, Speth F, Thieme S, Witkowski M, Berner R, Muntau A, Gersting S, Toepfner N, Pagel J, Paul K
VIRUSES-BASEL. 2023;15(7):1553.

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
Turkova A, White E, Kekitiinwa A, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe G, Moloantoa T, Srirompotong U, Mosia N, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi M, Klein N, Mujuru H, Kityo C, Cotton M, Ferrand R, Giaquinto C, Rojo P, Violari A, Gibb D, Ford D
LANCET CHILD ADOLESC. 2023;7(10):718-727.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
Amuge P, Lugemwa A, Wynne B, Mujuru H, Violari A, Kityo C, Archary M, Variava E, White E, Turner R, Shakeshaft C, Ali S, Nathoo K, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa A, Giaquinto C, Rojo P, Gibb D, Turkova A, Ford D
LANCET HIV. 2022;9(9):e638-e648.

HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
Baumann U, Schulze Sturm U, Königs C
MONATSSCHR KINDERH. 2022;170(11):997-1010.

Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
Cook A, Sharland M, Yau Y, Bielicki J
EXPERT REV ANTI-INFE. 2022;20(3):445-456.

Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants
Kobbe R, Schulze-Sturm U, Kurnaz P, Rau C, Tallarek A, Lütgehetmann M, Jordan S, Schmiedel S
AIDS. 2022;36(11):1613-1615.

Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Sorg A, Bergfeld L, Jank M, Corman V, Semmler I, Goertz A, Beyerlein A, Verjans E, Wagner N, Von Bernuth H, Lander F, Weil K, Hufnagel M, Spiekerkoetter U, Chao C, Naehrlich L, Muntau A, Schulze-Sturm U, Hansen G, Wetzke M, Jung A, Niehues T, Fricke-Otto S, Von Both U, Huebner J, Behrends U, Liese J, Schwerk C, Drosten C, Von Kries R, Schroten H
NAT COMMUN. 2022;13(1):.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Turkova A, Waalewijn H, Chan M, Bollen P, Bwakura-Dangarembizi M, Kekitiinwa A, Cotton M, Lugemwa A, Variava E, Ahimbisibwe G, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo C, Archary M, Ferrand R, Violari A, Gibb D, Burger D, Ford D, Colbers A
LANCET HIV. 2022;9(9):E627-E637.

Chronisch-rezidivierende Gonarthritis und Autoimmunneutropenie
Fröhlich A, Lehmberg K, Pagel J, Peldschus K, Schoof B, Schulze-Sturm U, Speth F
arthritis + rheuma. 2021;41(6):387-392.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen M, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S
J ALLERGY CLIN IMMUN. 2021;148(5):1332-1341.e5.

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
Turkova A, White E, Mujuru H, Kekitiinwa A, Kityo C, Violari A, Lugemwa A, Cressey T, Musoke P, Variava E, Cotton M, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch S, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe G, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb D
NEW ENGL J MED. 2021;385(27):2531-2543.

Unexpected high frequency of neurofibroma in the celiac ganglion of German cattle
Dammann I, Wemheuer W, Wrede A, Wemheuer W, Campe A, Petschenka J, Schulze-Sturm U, Hahmann U, Czerny C, Münster P, Brening B, Kreienbrock L, Herden C, Schulz-Schaeffer W
VET RES. 2020;51(1):82.

Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study
Noguera-Julian A, Calzada-Hernández J, Brinkmann F, Basu Roy R, Bilogortseva O, Buettcher M, Carvalho I, Chechenyeva V, Falcón L, Goetzinger F, Guerrero-Laleona C, Hoffmann P, Jelusic M, Niehues T, Ozere I, Shackley F, Suciliene E, Welch S, Schölvinck E, Ritz N, Tebruegge M
CLIN INFECT DIS. 2020;71(10):2561-2569.

Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study
Bélard S, Brand J, Schulze-Sturm U, Janda A, von Both U, Tacoli C, Alberer M, Kempf C, Stegemann M, Krüger R, Varnholt V, Blohm M, Reiter K, Zoller T, Suttorp N, Mall M, von Bernuth H, Gratopp A, Hübner J, Hufnagel M, Kobbe R, Kurth F
PEDIATR INFECT DIS J. 2019;38(11):e295-e300.

Reducing Hematologic Toxicity With Short Course Postexposure Prophylaxis With Zidovudine for HIV-1 Exposed Infants With Low Transmission Risk
Nguyen T, Kobbe R, Schulze-Sturm U, Blohm M, Hollwitz B, Hertling S, Becker C, Oommen P, Laws H, Martignoni F, Ole Jensen B, Olah K, Schmidtke S, Kreuels B, Vasconcelos M, Neubert J
PEDIATR INFECT DIS J. 2019;38(7):727-730.

Impact of refugee influx on the epidemiology of late-presenting HIV-infected pregnant women and mother-to-child transmission: comparing a southern and northern medical centre in Germany
Singer K, Schulze-Sturm U, Alba-Alejandre I, Hollwitz B, Nguyen T, Sollinger F, Eberle J, Hübner J, Kobbe R, Genzel-Boroviczény O, von Both U
INFECTION. 2019;47(5):847-852.

Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016
Mueller-Hermelink M, Kobbe R, Methling B, Rau C, Schulze-Sturm U, Auer I, Ahrens F, Brinkmann F
EUROSURVEILLANCE. 2018;23(12):4-9.

Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation
Kobbe R, Kolster M, Fuchs S, Schulze-Sturm U, Jenderny J, Kochhan L, Staab J, Tolosa E, Grimbacher B, Meyer T
GENE. 2016;586(2):234-8.

Dolutegravir in breast milk and maternal and infant plasma during breastfeeding
Kobbe R, Schalkwijk S, Dunay G, Eberhard J, Schulze-Sturm U, Hollwitz B, Degen O, Teulen M, Colbers A, Burger D
AIDS. 2016;30(17):2731-2733.

Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types
Wemheuer W, Benestad S, Wrede A, Schulze-Sturm U, Wemheuer W, Hahmann U, Gawinecka J, Schütz E, Zerr I, Brenig B, Bratberg B, Andréoletti O, Schulz-Schaeffer W
AM J PATHOL. 2009;175(6):2566-73.

Fatal familial insomnia: Clinical features and early identification
Krasnianski A, Bartl M, Sanchez Juan P, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar H, Schulz-Schaeffer W, Zerr I
ANN NEUROL. 2008;63(5):658-61.

Letzte Aktualisierung aus dem FIS: 20.12.2024 - 23:35 Uhr